PROCTER & GAMBLE HEALTH | AMRUTANJAN HEALTHCARE | PROCTER & GAMBLE HEALTH/ AMRUTANJAN HEALTHCARE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 44.7 | 77.4% | View Chart |
P/BV | x | 10.6 | 6.8 | 155.3% | View Chart |
Dividend Yield | % | 2.0 | 0.7 | 297.6% |
PROCTER & GAMBLE HEALTH AMRUTANJAN HEALTHCARE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
AMRUTANJAN HEALTHCARE Mar-23 |
PROCTER & GAMBLE HEALTH/ AMRUTANJAN HEALTHCARE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 955 | 561.8% | |
Low | Rs | 3,883 | 553 | 702.4% | |
Sales per share (Unadj.) | Rs | 740.7 | 129.9 | 570.3% | |
Earnings per share (Unadj.) | Rs | 138.2 | 13.6 | 1,014.3% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 15.4 | 1,006.8% | |
Dividends per share (Unadj.) | Rs | 95.00 | 4.60 | 2,065.2% | |
Avg Dividend yield | % | 2.1 | 0.6 | 336.7% | |
Book value per share (Unadj.) | Rs | 447.6 | 99.1 | 451.6% | |
Shares outstanding (eoy) | m | 16.60 | 29.23 | 56.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 5.8 | 107.5% | |
Avg P/E ratio | x | 33.5 | 55.3 | 60.5% | |
P/CF ratio (eoy) | x | 29.8 | 48.9 | 60.9% | |
Price / Book Value ratio | x | 10.3 | 7.6 | 135.8% | |
Dividend payout | % | 68.7 | 33.8 | 203.6% | |
Avg Mkt Cap | Rs m | 76,761 | 22,038 | 348.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 488 | 422.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 3,796 | 323.9% | |
Other income | Rs m | 184 | 145 | 126.5% | |
Total revenues | Rs m | 12,480 | 3,942 | 316.6% | |
Gross profit | Rs m | 3,247 | 445 | 729.0% | |
Depreciation | Rs m | 281 | 52 | 539.1% | |
Interest | Rs m | 8 | 2 | 345.3% | |
Profit before tax | Rs m | 3,142 | 536 | 585.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 138 | 613.5% | |
Profit after tax | Rs m | 2,295 | 398 | 576.1% | |
Gross profit margin | % | 26.4 | 11.7 | 225.1% | |
Effective tax rate | % | 27.0 | 25.7 | 104.7% | |
Net profit margin | % | 18.7 | 10.5 | 177.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 2,595 | 451.3% | |
Current liabilities | Rs m | 6,791 | 630 | 1,077.7% | |
Net working cap to sales | % | 40.0 | 51.8 | 77.3% | |
Current ratio | x | 1.7 | 4.1 | 41.9% | |
Inventory Days | Days | 263 | 51 | 511.7% | |
Debtors Days | Days | 343 | 317 | 108.2% | |
Net fixed assets | Rs m | 10,617 | 983 | 1,080.1% | |
Share capital | Rs m | 166 | 29 | 567.9% | |
"Free" reserves | Rs m | 7,265 | 2,868 | 253.3% | |
Net worth | Rs m | 7,431 | 2,897 | 256.5% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 3,578 | 624.0% | |
Interest coverage | x | 409.1 | 241.6 | 169.3% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 1.1 | 51.9% | |
Return on assets | % | 10.3 | 11.2 | 92.1% | |
Return on equity | % | 30.9 | 13.7 | 224.6% | |
Return on capital | % | 42.4 | 18.6 | 228.0% | |
Exports to sales | % | 0 | 2.7 | 0.0% | |
Imports to sales | % | 13.1 | 0.8 | 1,663.4% | |
Exports (fob) | Rs m | NA | 102 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 30 | 5,387.2% | |
Fx inflow | Rs m | 1,465 | 102 | 1,432.1% | |
Fx outflow | Rs m | 1,605 | 30 | 5,387.2% | |
Net fx | Rs m | -140 | 73 | -193.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 202 | 1,169.4% | |
From Investments | Rs m | -215 | -25 | 868.7% | |
From Financial Activity | Rs m | -985 | -150 | 656.9% | |
Net Cashflow | Rs m | 1,160 | 27 | 4,270.5% |
Indian Promoters | % | 0.0 | 50.6 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 8.7 | 230.3% | |
FIIs | % | 6.2 | 1.4 | 452.2% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 49.4 | 97.5% | |
Shareholders | 56,778 | 62,664 | 90.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | AMRUTANJAN HEALTH | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | -0.61% | 0.45% |
1-Month | -1.15% | 11.12% | 2.55% |
1-Year | 0.73% | 13.21% | 56.14% |
3-Year CAGR | -8.76% | 2.20% | 15.22% |
5-Year CAGR | 4.97% | 17.29% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the AMRUTANJAN HEALTH share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of AMRUTANJAN HEALTH the stake stands at 50.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of AMRUTANJAN HEALTH.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
AMRUTANJAN HEALTH paid Rs 4.6, and its dividend payout ratio stood at 33.8%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of AMRUTANJAN HEALTH.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.